NCI vs COEP
Comparison between Neo Concept International Group Holdings Ltd (NCI, Company) and Coeptis Therapeutics Holdings Inc. Common Stock (COEP, Company).
NCI is from the Consumer Cyclical sector, while COEP is from the Healthcare sector.
NCI vs COEP - Performance Comparison
Key Characteristics
Financial metrics and valuation ratios
NCI vs COEP - Historical Returns
Returns include dividend reinvestment.
NCI vs COEP - Annual Returns (2008 - 2026)
Returns include dividend reinvestment.
| Year | NCI | COEP |
|---|---|---|
| 2026 | +20.07% | N/A |
| 2025 | -62.35% | N/A |
| 2024 | -93.05% | N/A |
| 2022 | N/A | -29.92% |
| 2021 | N/A | +161.29% |
| 2020 | N/A | +4205.56% |
| 2019 | N/A | +133.33% |
| 2018 | N/A | +30.43% |
| 2017 | N/A | +53.33% |
| 2016 | N/A | -46.43% |
| 2015 | N/A | +11.43% |
| 2014 | N/A | -44.44% |
| 2013 | N/A | +950.00% |
| 2012 | N/A | -40.00% |
| 2011 | N/A | -92.31% |
| 2010 | N/A | -94.80% |
| 2009 | N/A | +25.00% |
| 2008 | N/A | +0.00% |
NCI vs COEP Drawdown Comparison
The maximum drawdown for NCI was -98.96%, occurring on Apr 13, 2026. This drawdown has not yet recovered.
The maximum drawdown for COEP was -99.94%, occurring on Apr 13, 2012. Recovery took 2232 trading sessions.
The current NCI drawdown is -97.12%. The current COEP drawdown is -58.13%.
| Rank | NCI | COEP |
|---|---|---|
| #1 | -98.96% Apr 23, 2024 - Apr 13, 2026 | -99.94% Mar 22, 2010 - Aug 11, 2020 |
| #2 | N/A | -96.95% Aug 11, 2020 - Jan 4, 2021 |
| #3 | N/A | -77.00% Feb 22, 2021 - Aug 29, 2022 |
| #4 | N/A | -60.00% Nov 19, 2009 - Mar 16, 2010 |
| #5 | N/A | -50.00% Dec 9, 2008 - Nov 19, 2009 |
| #6 | N/A | -27.50% Jan 6, 2021 - Jan 15, 2021 |
| #7 | N/A | -26.00% Jan 15, 2021 - Jan 28, 2021 |
| #8 | N/A | -24.24% Feb 11, 2021 - Feb 22, 2021 |
| #9 | N/A | -21.43% Feb 1, 2021 - Feb 9, 2021 |
| #10 | N/A | -15.48% Jan 4, 2021 - Jan 6, 2021 |
Correlation
Correlation between NCI and COEP is 0.00 which considered as a very weak or no correlation - the stocks move independently of each other.
Select Stocks to Compare
More Comparisons
Compare with similar stocks